Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.3810
-0.0132 (-3.35%)
At close: Jun 12, 2026, 4:00 PM EDT
0.4000
+0.0190 (4.99%)
Pre-market: Jun 15, 2026, 5:27 AM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $18.52 million as of June 15, 2026. Its market cap has decreased by -67.76% in one year.
Market Cap
18.52M
Enterprise Value
-19.11M
1-Year Change
-67.76%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $18.52M, a decrease of -95.80%. That is a compound annual growth rate of -46.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 18.52M | -39.79% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 19.75M |
| Traws Pharma | 19.39M |
| AEON Biopharma | 18.81M |
| Passage Bio | 18.64M |
| Lipocine | 18.63M |
| Tempest Therapeutics | 18.07M |
| Cellectar Biosciences | 17.82M |
| Exicure | 17.72M |